Stay informed with the latest litigation news. Explore now

IP Verse

Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof - EP2682388B1

EP2682388

MYLAN LABORATORIES
Application Number
EP13003519A
Filing Date
Jun 22, 2009
Status
Revoked
Apr 3, 2020
Grant Date
Jan 10, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2299989B1

Bibliography

The patent EP2682388B1 was granted to Mylan Laboratories on Jan 10, 2018 following the initial filing on Jun 22, 2009 under the application number EP13003519A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HOEFER & PARTNER PATENTANWALTE MBBOct 10, 2018 -
LES LABORATOIRES SERVIEROct 10, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents